Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

BEETON

Showing results (211-220 of 277) with videos related to

Pageof 28
Sort By:
Critical Care Medicine|July 9, 2005
A wet-primed extracorporeal membrane oxygenation circuit with hollow-fiber membrane oxygenator maintains adequate function for use during cardiopulmonary resuscitation after 2 weeks on standbyAnn Karimova, Alex Robertson, Nigel Cross, et al.
Diabetologia|April 18, 2000
Natural variants of human p85 alpha phosphoinositide 3-kinase in severe insulin resistance: a novel variant with impaired insulin-stimulated lipid kinase activityK C Baynes, C A Beeton, G Panayotou, et al.
Journal of Medical Microbiology|April 4, 2025
JMM Profile: <i>Mycoplasma genitalium</i>: a small, yet significant pathogenTia Rudman, Richard S Rowlands, Jorgen S Jensen, et al.
Plos One|November 19, 2013
A potent and selective peptide blocker of the Kv1.3 channel: prediction from free-energy simulations and experimental confirmationM Harunur Rashid, Germano Heinzelmann, Redwan Huq, et al.
The Journal of Biological Chemistry|November 7, 2007
The D-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferationChristine Beeton, Brian J Smith, Jennifer K Sabo, et al.
Clinical Immunology (Orlando, Fla.)|April 9, 2017
Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analogMark R Tanner, Rajeev B Tajhya, Redwan Huq, et al.
Experimental Neurology|October 9, 2025
Elastin-like polypeptide delivery of an NF-kB inhibitor for treatment of juvenile mild TBI complicated by high-fat diet consumptionJacob P Haskell, Allie M Smith, Ian G McGee, et al.
The Journal of Sports Medicine and Physical Fitness|October 6, 2025
Pedal power: female cyclists at 94.7 Ride Joburg face fewer illnesses but more injuries and finishing challengesDina C Janse VAN Rensburg, Xan Swart, Dimakatso Ramagole, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 29, 2021
Molecular exploration for Mycoplasma amphoriforme, Mycoplasma fermentans and Ureaplasma spp. in patient samples previously investigated for Mycoplasma pneumoniae infectionSafi U Rehman, Jessica Day, Baharak Afshar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 25, 2014
KCa1.1 inhibition attenuates fibroblast-like synoviocyte invasiveness and ameliorates disease in rat models of rheumatoid arthritisMark R Tanner, Xueyou Hu, Redwan Huq, et al.
Pageof 28

Showing results (211-220 of 277) with videos related to

Sort By:
Pageof 28
Critical Care Medicine|July 9, 2005
A wet-primed extracorporeal membrane oxygenation circuit with hollow-fiber membrane oxygenator maintains adequate function for use during cardiopulmonary resuscitation after 2 weeks on standbyAnn Karimova, Alex Robertson, Nigel Cross, et al.
Diabetologia|April 18, 2000
Natural variants of human p85 alpha phosphoinositide 3-kinase in severe insulin resistance: a novel variant with impaired insulin-stimulated lipid kinase activityK C Baynes, C A Beeton, G Panayotou, et al.
Journal of Medical Microbiology|April 4, 2025
JMM Profile: <i>Mycoplasma genitalium</i>: a small, yet significant pathogenTia Rudman, Richard S Rowlands, Jorgen S Jensen, et al.
Plos One|November 19, 2013
A potent and selective peptide blocker of the Kv1.3 channel: prediction from free-energy simulations and experimental confirmationM Harunur Rashid, Germano Heinzelmann, Redwan Huq, et al.
The Journal of Biological Chemistry|November 7, 2007
The D-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferationChristine Beeton, Brian J Smith, Jennifer K Sabo, et al.
Clinical Immunology (Orlando, Fla.)|April 9, 2017
Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analogMark R Tanner, Rajeev B Tajhya, Redwan Huq, et al.
Experimental Neurology|October 9, 2025
Elastin-like polypeptide delivery of an NF-kB inhibitor for treatment of juvenile mild TBI complicated by high-fat diet consumptionJacob P Haskell, Allie M Smith, Ian G McGee, et al.
The Journal of Sports Medicine and Physical Fitness|October 6, 2025
Pedal power: female cyclists at 94.7 Ride Joburg face fewer illnesses but more injuries and finishing challengesDina C Janse VAN Rensburg, Xan Swart, Dimakatso Ramagole, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 29, 2021
Molecular exploration for Mycoplasma amphoriforme, Mycoplasma fermentans and Ureaplasma spp. in patient samples previously investigated for Mycoplasma pneumoniae infectionSafi U Rehman, Jessica Day, Baharak Afshar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 25, 2014
KCa1.1 inhibition attenuates fibroblast-like synoviocyte invasiveness and ameliorates disease in rat models of rheumatoid arthritisMark R Tanner, Xueyou Hu, Redwan Huq, et al.
Pageof 28